MENU
+Compare
DAWN
Stock ticker: NASDAQ
AS OF
Apr 17 closing price
Price
$6.84
Change
+$0.08 (+1.18%)
Capitalization
693.26M

DAWN Day One Biopharmaceuticals Forecast, Technical & Fundamental Analysis

Day One Biopharmaceuticals Inc is a clinical-stage biopharmaceutical company... Show more

DAWN
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Ad is loading...
A.I.Advisor
a Summary for DAWN with price predictions
Apr 17, 2025

Momentum Indicator for DAWN turns negative, indicating new downward trend

DAWN saw its Momentum Indicator move below the 0 level on March 25, 2025. This is an indication that the stock could be shifting in to a new downward move. Traders may want to consider selling the stock or exploring put options. Tickeron's A.I.dvisor looked at 75 similar instances where the indicator turned negative. In of the 75 cases, the stock moved further down in the following days. The odds of a decline are at .

Price Prediction Chart

Technical Analysis (Indicators)

Bearish Trend Analysis

Following a 3-day decline, the stock is projected to fall further. Considering past instances where DAWN declined for three days, the price rose further in of 62 cases within the following month. The odds of a continued downward trend are .

The Aroon Indicator for DAWN entered a downward trend on April 17, 2025. This could indicate a strong downward move is ahead for the stock. Traders may want to consider selling the stock or buying put options.

Bullish Trend Analysis

The RSI Indicator points to a transition from a downward trend to an upward trend -- in cases where DAWN's RSI Indicator exited the oversold zone, of 25 resulted in an increase in price. Tickeron's analysis proposes that the odds of a continued upward trend are .

The Stochastic Oscillator suggests the stock price trend may be in a reversal from a downward trend to an upward trend. of 57 cases where DAWN's Stochastic Oscillator exited the oversold zone resulted in an increase in price. Tickeron's analysis proposes that the odds of a continued upward trend are .

The Moving Average Convergence Divergence (MACD) for DAWN just turned positive on April 11, 2025. Looking at past instances where DAWN's MACD turned positive, the stock continued to rise in of 36 cases over the following month. The odds of a continued upward trend are .

Following a 3-day Advance, the price is estimated to grow further. Considering data from situations where DAWN advanced for three days, in of 236 cases, the price rose further within the following month. The odds of a continued upward trend are .

DAWN may jump back above the lower band and head toward the middle band. Traders may consider buying the stock or exploring call options.

Fundamental Analysis (Ratings)

The Tickeron Valuation Rating of (best 1 - 100 worst) indicates that the company is fair valued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (1.379) is normal, around the industry mean (13.444). P/E Ratio (0.000) is within average values for comparable stocks, (62.833). Projected Growth (PEG Ratio) (0.000) is also within normal values, averaging (1.754). Dividend Yield (0.000) settles around the average of (0.026) among similar stocks. P/S Ratio (4.861) is also within normal values, averaging (250.783).

The Tickeron PE Growth Rating for this company is (best 1 - 100 worst), pointing to consistent earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.

The Tickeron Price Growth Rating for this company is (best 1 - 100 worst), indicating slightly worse than average price growth. DAWN’s price grows at a lower rate over the last 12 months as compared to S&P 500 index constituents.

The Tickeron SMR rating for this company is (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.

The Tickeron Profit vs. Risk Rating rating for this company is (best 1 - 100 worst), indicating that the returns do not compensate for the risks. DAWN’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 94, placing this stock worse than average.

View a ticker or compare two or three
DAWN
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Ad is loading...
A.I. Advisor
published Earnings

DAWN is expected to report earnings to fall 33.67% to -41 cents per share on May 07

Day One Biopharmaceuticals DAWN Stock Earnings Reports
Q1'25
Est.
$-0.42
Q4'24
Missed
by $0.17
Q3'24
Beat
by $0.70
Q2'24
Beat
by $0.70
Q1'24
Missed
by $0.07
The last earnings report on February 25 showed earnings per share of -62 cents, missing the estimate of -46 cents. With 1.19M shares outstanding, the current market capitalization sits at 693.26M.
A.I. Advisor
published General Information

General Information

Industry Biotechnology

Profile
Fundamentals
Details
Industry
N/A
Address
2000 Sierra Point Parkway
Phone
+1 650 484-0899
Employees
155
Web
https://www.dayonebio.com
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
GME26.780.53
+2.02%
GameStop Corp
AAPL196.982.71
+1.39%
Apple
SPY526.410.75
+0.14%
SPDR® S&P 500® ETF
TSLA241.37-0.18
-0.07%
Tesla
BTC.X84450.805000-444.945300
-0.52%
Bitcoin cryptocurrency

DAWN and Stocks

Correlation & Price change

A.I.dvisor indicates that over the last year, DAWN has been loosely correlated with ACLX. These tickers have moved in lockstep 45% of the time. This A.I.-generated data suggests there is some statistical probability that if DAWN jumps, then ACLX could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To DAWN
1D Price
Change %
DAWN100%
+1.18%
ACLX - DAWN
45%
Loosely correlated
+2.19%
RVMD - DAWN
45%
Loosely correlated
+1.55%
SYRE - DAWN
44%
Loosely correlated
+2.01%
DNLI - DAWN
43%
Loosely correlated
+1.51%
NRIX - DAWN
43%
Loosely correlated
+4.49%
More